secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalyn Pharma Inc. (AVLN)
CIK:        0001540171
Form:       8-K
Filed at:   2026-07-01T21:20:55+00:00
Accession:  0001193125-26-292834
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalyn Pharma expands Boston sublease by ~4,934 sq ft; lease payments rise ~$924k
--------------------------------------------------------------------------------

- Expands subleased premises from ~8,774 to ~13,708 rentable square feet at 105 W First Street, Boston.
- Future minimum lease payments increase by ~$924,000 over the remaining term ending Jan 31, 2029.
- Expansion effective upon master landlord's consent; Sublandlord may rescind if consent not received within 30 days.
- Base rent for Expansion Premises starts at $28,781.67/month, escalating to $30,534.47/month in final year.
- Subtenant gets 2 garage parking passes (up from 1) and use of existing furniture in the expansion space.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/0001193125-26-292834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/ck0001540171-20260629.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-292834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer